Related Experiment Videos
[Histamine release from human leukocytes by human recombinant interleukin-3]
1Department of Pediatrics, Fujita Health University, School of Medicine.
Arerugi = [Allergy]
|May 1, 1990
Summary
Human recombinant interleukin-3 (hrIL-3) triggers histamine release from leukocytes, distinct from other stimuli. This process is calcium-dependent and affects subsequent histamine responses.
Area of Science:
- Immunology
- Cell Biology
Context:
- Leukocytes are key immune cells involved in allergic responses.
- Histamine release from leukocytes is a critical mediator of inflammation.
Purpose:
- To investigate the mechanism of histamine release induced by human recombinant interleukin-3 (hrIL-3).
- To compare hrIL-3-induced histamine release with other known stimuli.
Summary:
- Human recombinant interleukin-3 (hrIL-3) induces histamine release from human leukocytes in vitro.
- This release is calcium-dependent and differs mechanistically from stimuli like anti-IgE, thrombin, f-met peptide, and A23187.
- Pre-treatment with hrIL-3 modulates subsequent histamine release by other agents.
Impact:
- Elucidates novel pathways in immune cell activation.
- Provides insights into the role of IL-3 in inflammatory processes.
- Suggests potential therapeutic targets for conditions involving histamine release.